Targeting a neoantigen derived from a common TP53 mutation

(tumor protein p53) is the most commonly mutated cancer driver gene, but drugs that target mutant tumor suppressor genes, such as , are not yet available. Here, we describe the identification of an antibody highly specific to the most common mutation (R175H, in which arginine at position 175 is repl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2021-03, Vol.371 (6533)
Hauptverfasser: Hsiue, Emily Han-Chung, Wright, Katharine M, Douglass, Jacqueline, Hwang, Michael S, Mog, Brian J, Pearlman, Alexander H, Paul, Suman, DiNapoli, Sarah R, Konig, Maximilian F, Wang, Qing, Schaefer, Annika, Miller, Michelle S, Skora, Andrew D, Azurmendi, P Aitana, Murphy, Michael B, Liu, Qiang, Watson, Evangeline, Li, Yana, Pardoll, Drew M, Bettegowda, Chetan, Papadopoulos, Nickolas, Kinzler, Kenneth W, Vogelstein, Bert, Gabelli, Sandra B, Zhou, Shibin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!